Novem Group’s Morgan Stanley MS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$393K Sell
1,879
-369
-16% -$73.1K 0.04% 309
2026
Q1
$370K Sell
2,248
-8
-0.4% -$1.39K 0.04% 312
2025
Q4
$401K Sell
2,256
-132
-6% -$22K 0.05% 298
2025
Q3
$380K Sell
2,388
-138
-5% -$20.4K 0.04% 298
2025
Q2
$356K Sell
2,526
-119
-4% -$14.6K 0.04% 290
2025
Q1
$309K Buy
2,645
+640
+32% +$82.5K 0.04% 282
2024
Q4
$252K Buy
+2,005
New +$247K 0.04% 310

Other funds holding MS

Novem Group's MS Position: Q2 2026 in Review

Novem Group reduced its Morgan Stanley (MS) stake by 16% in Q2 2026, selling an estimated $73.1K and leaving 1,879 shares worth $393K. The position accounts for 0.04% of the portfolio, ranked #309.

Novem Group first reported a position in MS in Q4 2024 and has held it in 7 quarters since. The position peaked at $401K in Q4 2025. 936 funds tracked by Wall St. Rank hold MS as of Q2 2026.

  • Novem Group held 1,879 shares of Morgan Stanley worth $393K as of Q2 2026.
  • Novem Group sold 369 Morgan Stanley shares in Q2 2026, an estimated $73.1K.
  • Morgan Stanley made up 0.04% of Novem Group's portfolio in Q2 2026, its #309 holding.
  • Novem Group first reported a position in Morgan Stanley in Q4 2024 and has held it in 7 quarters since.
  • Novem Group's Morgan Stanley position peaked at $401K in Q4 2025.
  • 936 funds tracked by Wall St. Rank held Morgan Stanley as of Q2 2026.

Based on Novem Group's 13F filing for Q2 2026, filed 21 Jul 2026.